Medical/Pharmaceuticals
BIORCHESTRA appointed Dr. Gabriel Helmlinger (Ph.D., DABT) as Head of Translational and Clinical Pharmacology, Toxicology
BOSTON, Mass., Aug. 23, 2022 /PRNewswire/ -- BIORCHESTRA, headquartered in Daejeon,South Korea, appointed Dr. Gabriel Helmlinger (Ph.D., D.A.B.T.) as Vice-President, Head of Translational & Clinical Pharmacology, Toxicology. Dr. Helmlinger brings 25 years of drug research and clinical development...
2022-08-23 20:00
2078
AESOP Technology Wins Coveted Place in Mayo Clinic Platform_Accelerate Program to Build Better AI Model for Healthcare
SAN FRANCISCO, Aug. 22, 2022 /PRNewswire/ -- AESOP Technology
2022-08-23 00:00
2318
AVELOS THERAPEUTICS ANNOUNCES $8 MILLON SERIES A FUNDING ROUND
Seoul-Based Biotechnology Company to Use Financing for Expanding Oncology Drug Discovery and Development SEOUL, South Korea, Aug. 22, 2022 /PRNewswire/ -- Innovative biotechnology company specializing in new drug discovery and development, Avelos Therapeutics, has received a glowing endorsement ...
2022-08-22 20:00
2004
Ubie, Japanese Health-tech Startup, Raises $26.2 Million in Series C, $59.8 Million in Total
- Bringing Unprecedented Medical Experience by Strengthening Partnerships with Pharmaceutical Companies inJapan and U.S. to Build Medical Data Platform - TOKYO and SINGAPORE, Aug. 22, 2022 /PRNewswire/ -- Ubie, Inc., a healthcare AI startup with the mission "To develop a healthcare guide for ever...
2022-08-22 14:00
2153
Biosion, Inc. Appoints Steven Knapp, Pharm.D. as Chief Regulatory & Quality Officer
NEWARK, Del. and NANJING, China, Aug. 22, 2022 /PRNewswire/ -- Biosion, Inc. ("Biosion"), a leading global R&D biotechnology company, today announced the appointment ofSteven Knapp, PharmD., as Chief Regulatory & Quality Officer. In this position, he is responsible for the strategic leadership...
2022-08-22 13:00
1775
AIRS Medical Raises $20M in Series B Funding
SEOUL, South Korea, Aug. 19, 2022 /PRNewswire/ -- AIRS Medical, a healthcare startup based inSouth Korea and a member of the Born2Global Centre, recently announced that it has raised approximately$20M in Series B funding. The round of Series B funding welcomed new investors Q Capital Partners and...
2022-08-19 21:00
2422
I-Mab to Report Business and Corporate Updates and Financial Results for the Six Months Ended June 30, 2022 on August 30, 2022
- Major updates will focus on global clinical development of core assets, upcoming milestones and financial results - The Company will update on potential implementation of a comprehensive share purchase program by the Company and current shareholders - Conference Calls Scheduled at 7:00 a.m....
2022-08-19 21:00
2210
World's First CAR-T for NMOSD Treatment, IASO Biotherapeutics' Equecabtagene Autoleucel, Receives IND Approval by NMPA
SHANGHAI, NANJING, China and SAN JOSE, Calif., Aug. 19, 2022 /PRNewswire/ -- IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody products, announced today that the Center for Drug ...
2022-08-19 18:41
1971
J INTS BIO successfully held its 1st International Advisory Board Meeting for its Novel Oral 4th Generation EGFR TKI (JIN-A02) in Vienna, Austria during WCLC
SEOUL, South Korea, Aug. 19, 2022 /PRNewswire/ -- J INTS BIO announced that it held its 1st International Advisory Board Meeting for its Novel Oral 4th Generation EGFR-TKI 'JIN-A02' on the sideline of the 2022 IASLC World Conference on Lung Cancer held inVienna, Austria, on 7th August. This follo...
2022-08-19 16:00
1100
Nuance Pharma Announces Clearance of IND Application for Ensifentrine Pivotal Clinical Trials for COPD in China
SHANGHAI, Aug. 18, 2022 /PRNewswire/ -- Nuance Pharma ("the Company") announces the Center for Drug Evaluation ("CDE") has approved its Investigational New Drug ("IND") application supporting its pivotal clinical trial ofEnsifentrine for the maintenance treatment of chronic obstructive pulmonary ...
2022-08-19 11:24
1606
Sirnaomics Doses the First Patient in Phase I/II Clinical Study of RNAi Therapeutic STP705 for Treatment of Facial Squamous Cell Skin Cancer In Situ
Data results will be available in Q1 2023 GAITHERSBURG, Md. and SUZHOU, China, Aug. 18, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that the Compa...
2022-08-18 23:46
1434
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand for Adolescents Aged 12 Through 17
* Nuvaxovid™ is New Zealand's only protein-based COVID-19 vaccine GAITHERSBURG, Md., Aug. 18, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that New...
2022-08-18 21:06
2289
CG Pharmaceuticals Announces First Patient Dosed in Phase 1b/2 Study Evaluating Ivaltinostat for the Treatment of Pancreatic Adenocarcinoma
ORINDA, Calif. and SEOUL, South Korea, Aug. 18, 2022 /PRNewswire/ -- CG Pharmaceuticals, Inc. announced the first patient dosed with the ivaltinostat and capecitabine combination therapy for the Phase1b/2 pancreatic adenocarcinoma (PDAC) maintenance study. Commencement of treatment for the first...
2022-08-18 21:00
1441
Case Report of Long Term Complete Response in Hepatocellular Carcinoma to CARsgen's GPC3 CAR T Cells (CT011) Published in Frontiers in Immunology
SHANGHAI, Aug. 18, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that a case report, titled "Long Term Complete Response of Advanced H...
2022-08-18 20:50
1851
Standigm names Carl Foster chief business officer to expand strategic partnerships for AI drug discovery
Veteran biotech and pharmaceutical executive will help company increase its
growth and international impact
SEOUL, South Korea, Aug. 18, 2022 /PRNewswire/ -- Standigm Inc.
2022-08-18 20:30
1795
Ybrain Receives Translational Research Award 2022 Neuroergonomics Conference & NYC Neuromodulation Conference
NEW YORK, Aug. 18, 2022 /PRNewswire/ -- Ybrain recently received the
Translational Research Award at this year'sNeuroergonomics Conference and NYC
Neuromodulation Conference
2022-08-18 20:00
1907
GenFleet Receives FDA Approval for Phase II Study of RIPK1 Inhibitor (GFH312)
SHANGHAI, Aug. 18, 2022 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has approved the clinical trial application for GFH312 in a randomized, double-blind...
2022-08-18 19:00
1739
Zylox-Tonbridge maintains strong revenue and gross profit growth, including gross margin improvement driven by its platform-based strategy in 1H22
HANGZHOU, China, Aug. 18, 2022 /PRNewswire/ -- On August 15, Zylox-Tonbridge (2190.HK, "the Company") released its 2022 interim results. The Company's revenue increased 113.7% YoY to RMB 1.53 billion in the first six months of 2022. The revenue of neurovascular interventional products business i...
2022-08-18 14:57
1754
WuXi Biologics Reports Strong 2022 Interim Results
Revenue Increased by 63.5% Y-o-Y to RMB7,206.4 Million Gross Profit Increased by 48.6% Y-o-Y to RMB3,413.2 Million Net Profit Grew by 39.2% Y-o-Y to RMB2,621.2 Million Adjusted Net Profit Rose by 60.9% to RMB2,914.9 Million Total Backlog Reached US$18,467 Million * * * Non-COVID Re...
2022-08-17 21:32
3546
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand as a First and Second Booster for Adults
* Nuvaxovid™ is New Zealand's first and only protein-based COVID-19 vaccine * Nuvaxovid™ can now be used as a first or second booster dose for adults aged 18 and older vaccinated with any primary series vaccine GAITHERSBURG, Md., Aug. 17, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a bi...
2022-08-17 20:00
3219
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
9236
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7714